Literature DB >> 23333814

The influence of propofol, remifentanil and lidocaine on the tone of human bronchial smooth muscle.

Paola Rogliani1, Luigino Calzetta, Erino A Rendina, Domenico Massullo, Mario Dauri, Barbara Rinaldi, Annalisa Capuano, Maria Gabriella Matera.   

Abstract

BACKGROUND: Bronchoscopy is generally a safe procedure, but the induction of anaesthesia can induce bronchospasm. Consequently we investigated the influence of propofol, remifentanil and lidocaine on the tone of the human bronchial smooth muscle.
MATERIALS AND METHODS: The influence of propofol, remifentanil and lidocaine on the contractile response of human bronchial smooth muscle to electrical field stimulation (EFS) has been evaluated. The role of capsaicin-sensitive sensory nerves and of inducible nitric oxide synthase has also been assessed. Furthermore, the interaction between these three dugs has been measured by Bliss Independence (BI) theory. Statistical significance (P < 0.05) was assessed by Student's t test or ANOVA.
RESULTS: Propofol (1.3 μg ml(-1)) and lidocaine (1 mg ml(-1)) reduced the baseline tone of bronchial rings (-14.45 ± 4.53% and -33.40 ± 1.07%, respectively, P < 0.05), whereas remifentanil had not such effect. Aminoguanidine prevented the relaxant effect of propofol. Propofol did not alter the bronchial contractile response to EFS following 30 min of treatment, whereas remifentanil enhanced the bronchial tension (133.83 ± 9.38%, control 101.93 ± 6.82%, P < 0.05 P < 0.05) and lidocaine completely abolished the contractility at 1 mg ml(-1) (P < 0.05). The desensitization of capsaicin-sensitive sensory nerves normalized the hyperresponsiveness induced by remifentanil (-26.77 ± 1.68%, P < 0.05). Significant BI antagonism (P < 0.001) was detected for propofol and lidocaine on the bronchial hyperresponsiveness induced by remifentanil.
CONCLUSION: Propofol and remifentanil may be used safely for bronchoscopy, although remifentanil should be associated with propofol or lidocaine to prevent the potential opioid-mediated bronchospasm.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23333814     DOI: 10.1016/j.pupt.2013.01.002

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  10 in total

1.  Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling.

Authors:  Barbara Rinaldi; Maria Donniacuo; Loredana Sodano; Giulia Gritti; Eugenio Martuscelli; Augusto Orlandi; Concetta Rafaniello; Francesco Rossi; Luigino Calzetta; Annalisa Capuano; Maria Gabriella Matera
Journal:  Br J Pharmacol       Date:  2015-05-12       Impact factor: 8.739

2.  -Effects of Local Anesthetics on Smooth Muscle Tissue in Rat Trachea: An In Vitro Study.

Authors:  Ali Onur Erdem; Varlık K Erel; Özlem Girit; Hasan Erdoğan; Sezen Özkısacık; Mesut Yazıcı
Journal:  Turk Thorac J       Date:  2020-07

3.  Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: Synergy of triple combination therapy on human airway smooth muscle ex vivo.

Authors:  Paola Rogliani; Maria Gabriella Matera; Francesco Facciolo; Clive Page; Mario Cazzola; Luigino Calzetta
Journal:  Br J Pharmacol       Date:  2020-01-29       Impact factor: 8.739

4.  Effects of sex hormones on bronchial reactivity during the menstrual cycle.

Authors:  Maria Matteis; Francesca Polverino; Giuseppe Spaziano; Fiorentina Roviezzo; Carlo Santoriello; Nikol Sullo; Maria Rosaria Bucci; Francesco Rossi; Mario Polverino; Caroline A Owen; Bruno D'Agostino
Journal:  BMC Pulm Med       Date:  2014-07-01       Impact factor: 3.317

5.  Propofol and remifentanil at moderate and high concentrations affect proliferation and differentiation of neural stem/progenitor cells.

Authors:  Qing Li; Jiang Lu; Xianyu Wang
Journal:  Neural Regen Res       Date:  2014-11-15       Impact factor: 5.135

6.  Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways.

Authors:  Luigino Calzetta; Maria Gabriella Matera; Francesco Facciolo; Mario Cazzola; Paola Rogliani
Journal:  Respir Res       Date:  2018-04-12

7.  Application of Intravenous Lidocaine in Obese Patients Undergoing Painless Colonoscopy: A Prospective, Randomized, Double-Blind, Controlled Study.

Authors:  Xiaoxiao Li; Xueli Lv; Zhenfei Jiang; Xinrui Nie; Xinghe Wang; Tong Li; Lianyi Zhang; Su Liu
Journal:  Drug Des Devel Ther       Date:  2020-08-27       Impact factor: 4.162

8.  Pre-administration of remifentanil in target-controlled propofol and remifentanil anesthesia prolongs anesthesia induction in neurosurgical patients: A double-blind randomized controlled trial.

Authors:  Jin Hee Ahn; Doyeon Kim; Ik Soo Chung; Jeong Jin Lee; Eun Kyung Lee; Ji Seon Jeong
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

9.  Novel and effective balanced intravenous-inhalant anaesthetic protocol in swine by using unrestricted drugs.

Authors:  Luigino Calzetta; Piero Rossi; Pierluigi Bove; Pietro Alfonsi; Luigi Bonizzi; Paola Roncada; Roberta Bernardini; Edoardo Ricciardi; Mauro Montuori; Elena Pistocchini; Paolo Mauti; Maurizio Mattei
Journal:  Exp Anim       Date:  2014-07-15

10.  Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells.

Authors:  Mario Cazzola; Luigino Calzetta; Ermanno Puxeddu; Josuel Ora; Francesco Facciolo; Paola Rogliani; Maria Gabriella Matera
Journal:  Respir Res       Date:  2016-06-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.